RA antigenic peptides

Details for Australian Patent Application No. 2004263303 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Vogt, Anne; Kropshofer, Harald; Berntenis, Nikolaos; Spindeldreher, Sebastian Thomas; Buurman, Gerrit; Zolg, Werner; Mueller, Bernd Christian

Agent Spruson & Ferguson

Pub. Number AU-A-2004263303

PCT Pub. Number WO2005/014622

Priority 03017551.7 07.08.03 EP

Filing date 30 July 2004

Wipo publication date 17 February 2005

International Classifications

C07K 1/22 (2006.01) General processes for the preparation of peptides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 1/32 (2006.01) General processes for the preparation of peptides

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 14/74 (2006.01) Peptides having more than 20 amino acids

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014622 Priority application(s): WO2005/014622

24 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263306-Piperazine with or-substituted phenyl group and their use as GLYT1 inhibitors

2004263300-Benzoxazinone-derived sulfonamide compounds, their preparation and use as medicaments